CYBERJAYA: DXN Holdings Bhd, a leading global manufacturer of nutraceutical products, posted revenue of RM1.42 billion for the nine months (9M) ending February 28, 2026 (FY26) from RM1.44 billion posted in the same period last year, marginally
affected by unfavourable currency translation due to the appreciation of the ringgit.
Excluding foreign currency translation effects, DXN’s revenue would have delivered a normalised year-on-year (YoY) growth of 14.5%, supported by strong local-currency revenue growth across Peru, Bolivia, India and the Middle East of between 10.0% and 43.0% YoY, reflecting the resilience of DXN’s business fundamentals.
Meanwhile, earnings before interest, tax, depreciation & amortisation (EBITDA) amounted to RM407.1 million for 9M FY26 compared to RM435.4 million posted in 9M FY25, reflecting higher aircraft leasing costs attributable to a longer leasing duration in the current period and the absence of a one-off indirect tax refund recognised last year.
However, the decline in EBITDA was partially mitigated by lower foreign
exchange losses compared with 9M FY25.
Net profit came in at RM208.9 million for 9M FY26 compared to RM244.3 million posted in 9M FY25.
In line with its dividend policy, the board declared a third interim dividend of 0.8 sen per share for Q3 FY26, bringing total dividends declared for 9M FY26 to 2.5 sen per share.
In total, DXN declared dividends totalling RM124.3 million during this period, representing a 59.5% payout ratio.
DXN executive chairman and founder Datuk Lim Siow Jin said the company’s performance during the period was delivered against a challenging backdrop of geopolitical tensions, foreign exchange volatility, and inflationary pressures.
He said that, despite these headwinds, DXN’s underlying business remained resilient, supported by healthy demand across key markets and the strength of its global member network, particularly in Latin America, Europe, and Africa.
Latin America, which accounts for over 60% of group revenue, remains DXN’s largest and fastest-growing region, driven by a localisation strategy to manufacture closer to end markets.
In Peru, the group is investing RM107.2 million in a production facility scheduled to commence operations in 2026, which will produce a wide range of beverages, powdered foods, supplements, and juices for the regional market.
This will be followed by an RM111.1 million production facility in Bolivia in 2027, expanding product offerings and strengthening DXN’s downstream presence
across high-growth markets.
These downstream investments are complemented by an upstream commitment in Brazil, where DXN is investing RM33.8 million in land for coffee cultivation and processing.
The integrated development will enhance supply chain reliability and reduce exposure to raw material price volatility, reinforcing DXN’s vertically integrated business model and supporting long-term scalability across Latin America.
“As we continue to navigate these external uncertainties, our focus remains on disciplined execution of our long-term strategy and strengthening supply resilience.
“Across Brazil, Bolivia, Peru and Malaysia, we are progressing upstream initiatives to strengthen our coffee supply chain, alongside the development of new facilities to expand production capacity to support a broader range of products as operations scale,” he said.
On a YoY basis, DXN’s revenue for Q3 FY26 ended November 30, 2025 (FY26) stood at RM463.3 million, lower than Q3 FY25’s RM486.1 million.
The performance was primarily attributed to the appreciation of the ringgit
as well as advanced purchases made ahead of price revisions by members in the Middle East in September 2025.
Despite this, Peru, India, and Bolivia posted local currency revenue growth
rates ranging from 4.8% to 39.0%.
In line with the softer revenue, DXN recorded an EBITDA of RM131.7 million compared to Q3 FY25’s RM158.0 million due to the top-line performance.
Subsequently, DXN reported a net profit of RM64.8 million in Q3, in contrast to last year’s RM92.8 million.
DXN remains financially strong, with cash and cash equivalents of RM637.1 million as at November 30, 2025, exceeding total borrowings of RM187.9 million.
Furthermore, net operating cash flow stood strong at RM240.0 million for the period.
